Science libraryBiblioteka nauke

Research profile 06Istraživački profil 06

Wolverine StackWolverine Stack

A non-standardized stack name often associated with BPC-157 and a thymosin-related material. Component and stack-level human evidence are very limited.Nestandardizovani naziv staka koji se često povezuje sa BPC-157 i materijalom povezanim sa timozinom. Dokazi kod ljudi za komponente i ceo stak veoma su ograničeni.

Anti-aging & longevityAnti-aging i dugovečnostVariable blend · mostly preclinicalPromenljiva mešavina · uglavnom pretkliničkiNo dosing guidanceBez smernica za doziranje
Evidence profileProfil dokazaWolverine StackWolverine Stack
Evidence levelNivo dokazaVariable blend · mostly preclinicalPromenljiva mešavina · uglavnom pretklinički
Editorial ruleUredničko praviloFindings and limits shown togetherNalazi i ograničenja prikazani zajedno

A research category organizes reading. It is not a promise of an individual outcome.Istraživačka kategorija organizuje čitanje. Ona nije obećanje individualnog ishoda.

Molecular classMolekulska klasaNon-standardized multi-component stackNestandardizovani višekomponentni stak
Research statusStatus istraživanjaMostly cell and animal research; exact composition variesUglavnom ćelijska i životinjska istraživanja; tačan sastav varira
Human evidenceDokazi kod ljudiNo established clinical evidence for the named stackNema utvrđenih kliničkih dokaza za imenovani stak
Profile reviewedProfil pregledan7 September 20267. septembar 2026.

Plain-language overviewJasan pregled

Component evidence is not stack evidence.Dokazi o komponentama nisu dokazi o staku.

“Wolverine Stack” is a marketing nickname rather than a standardized research formulation. It is often used for a BPC-157 and TB-500 pairing, but the components, forms and ratios must be confirmed for each supplier.„Wolverine Stack“ je marketinški nadimak, a ne standardizovana istraživačka formulacija. Često se koristi za kombinaciju BPC-157 i TB-500, ali se komponente, oblici i odnosi moraju potvrditi za svakog dobavljača.

Published BPC-157 tendon-healing work is primarily in cells, explants and rodents. Full-length thymosin β4 also has preclinical wound-healing research, but evidence for full-length thymosin β4 cannot automatically be transferred to a fragment sold as TB-500—or to a blend.Objavljeni radovi o BPC-157 i zarastanju tetiva uglavnom su sprovedeni na ćelijama, eksplantima i glodarima. Timozin β4 pune dužine takođe ima pretklinička istraživanja zarastanja rana, ali se dokazi za timozin β4 pune dužine ne mogu automatski preneti na fragment koji se prodaje kao TB-500—niti na mešavinu.

Read the educational boundaryPročitajte edukativnu granicu

Selected primary sourcesOdabrani primarni izvori

Open the study.
Check the model.
Otvorite studiju.
Proverite model.

These are curated starting points, not an exhaustive bibliography. Live PubMed and ClinicalTrials.gov searches below expose the broader and changing record.Ovo su odabrane polazne tačke, a ne iscrpna bibliografija. Pretrage uživo na PubMed-u i ClinicalTrials.gov u nastavku prikazuju širi zapis koji se menja.

2011
BPC-157 preclinical tendon studyPretklinička studija BPC-157 na tetivi

BPC-157 and tendon fibroblast outgrowth, survival and migrationBPC-157 i rast, preživljavanje i migracija fibroblasta tetive

Journal of Applied Physiology

The work used rat tendon explants and cultured fibroblasts. It did not establish healing efficacy or safety in people.Rad je koristio eksplantate tetiva pacova i kultivisane fibroblaste. Nije utvrdio efikasnost zarastanja niti bezbednost kod ljudi.

2003
BPC-157 rodent tendon studyStudija BPC-157 na tetivi glodara

BPC-157 and healing of transected rat Achilles tendonBPC-157 i zarastanje presečene Ahilove tetive pacova

Journal of Orthopaedic Research

An animal model reported tendon-healing findings. Animal outcomes cannot establish human clinical benefit.Životinjski model prijavio je nalaze o zarastanju tetive. Ishodi kod životinja ne mogu utvrditi kliničku korist kod ljudi.

2004
Thymosin β4 preclinical researchPretkliničko istraživanje timozina β4

Thymosin β4 promotes dermal wound repair in ratsTimozin β4 podstiče popravku kožnih rana kod pacova

Annals of the New York Academy of Sciences

This source concerns full-length thymosin β4 in a rodent model, not necessarily TB-500 material and not the named stack.Ovaj izvor se odnosi na timozin β4 pune dužine u modelu glodara, ne nužno na materijal TB-500 niti na imenovani stak.

Living literatureŽiva literatura

Continue with current databases.Nastavite u aktuelnim bazama podataka.

Search results can change as papers and trial records are added or updated.Rezultati pretrage mogu se menjati kako se radovi i zapisi studija dodaju ili ažuriraju.

Reasonable interpretationRazumno tumačenje

What the evidence supports.Šta dokazi podržavaju.

  • BPC-157 has generated tendon and fibroblast findings in preclinical models.BPC-157 je proizveo nalaze o tetivama i fibroblastima u pretkliničkim modelima.
  • Full-length thymosin β4 has preclinical wound-healing literature.Timozin β4 pune dužine ima pretkliničku literaturu o zarastanju rana.
  • These findings justify further research, not a clinical recovery claim.Ovi nalazi opravdavaju dalja istraživanja, a ne kliničku tvrdnju o oporavku.
Critical boundaryKritična granica

What it does not establish.Šta se time ne dokazuje.

  • A proven healing, recovery, anti-aging or longevity benefit in humans.Dokazanu korist za zarastanje, oporavak, anti-aging ili dugovečnost kod ljudi.
  • Equivalence between TB-500 material and full-length thymosin β4.Ekvivalentnost između materijala TB-500 i timozina β4 pune dužine.
  • Synergy, safety or efficacy for the combined stack.Sinergiju, bezbednost ili efikasnost kombinovanog staka.

Future verificationBuduća verifikacija

The literature explains the target. The report examines the sample.Literatura objašnjava cilj. Izveštaj ispituje uzorak.

A record must state the actual components rather than only “Wolverine Stack.” The lab target must distinguish BPC-157, the exact thymosin-related sequence or material, and each nominal quantity; ambiguous TB-500 identity must remain visibly unresolved.Zapis mora navesti stvarne komponente, a ne samo „Wolverine Stack“. Laboratorijski cilj mora razlikovati BPC-157, tačnu sekvencu ili materijal povezan sa timozinom i svaku nominalnu količinu; nejasan identitet TB-500 mora ostati vidljivo nerešen.

Understand the test fieldsRazumite polja testiranja
Related guidePovezani vodič

Storage claims need formulation-specific evidence too.Tvrdnje o čuvanju takođe zahtevaju dokaze specifične za formulaciju.

Storage & handlingČuvanje i rukovanje